HIV Disclosure and Medication Adherence, a Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Patient Adherence
研究概览
简要总结
The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.
详细描述
Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.
Adherence is measured by electronic monitoring and pill count.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HIV Infection
- •Enrolled in the adherence-enhancing program
排除标准
- •Inclusion visit
- •Not french or english speaker
结局指标
主要结局
Patient Adherence
时间窗: 30 days before survey
Electronic monitoring of adherence during 30 days before survey
次要结局
- Patient Adherence(90 days before survey)
研究者
Marie Schneider
Pharmacist, PhD
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland